When individuals call Unlimited Sciences’ psychedelic hotline at 888-210-3553, they talk with a person who provides evidence-based information gleaned not only from the organization’s own studies but also from those being done around the world.
TORONTO - Cybin Inc. , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today.
- Abstract entitled, “Structure-activity of 2C-X psychedelics to develop a novel 5-HT2A receptor full agonist with therapeutic potential” -
- Highlights preclinical work done to support.
Join Lynn Marie Morski, a physician, attorney, and president of the Psychedelic Medicine Association. We'll explore the historical roots of psilocybin, its emerging clinical applications, safety considerations, and the role of health care professionals in educating patients.